UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Antiviral research, 2021-11, Vol.195, p.105180-105180, Article 105180

2021

Volltextzugriff (PDF)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

Emerging infectious diseases, 2018-09, Vol.24 (9), p.1696-1699

2018

Volltextzugriff (PDF)

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

Scientific reports, 2015-10, Vol.5 (1), p.14775-14775, Article 14775

2015

Volltextzugriff (PDF)

Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs

Journal of virology, 2021-06, Vol.95 (14), p.e0039721-e0039721

2021

Volltextzugriff (PDF)

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4673-4680

2013

Volltextzugriff (PDF)

Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever

PLoS neglected tropical diseases, 2011-10, Vol.5 (10), p.e1342

2011

Volltextzugriff (PDF)

Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques

Antiviral research, 2020-09, Vol.181, p.104858-104858, Article 104858

2020

Volltextzugriff (PDF)

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever

PLoS neglected tropical diseases, 2013-12, Vol.7 (12), p.e2614

2013

Volltextzugriff (PDF)

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses

Nature communications, 2023-09, Vol.14 (1), p.5650-15, Article 5650

2023

Volltextzugriff (PDF)

A potent Lassa virus antiviral targets an arenavirus virulence determinant

PLoS pathogens, 2018-12, Vol.14 (12), p.e1007439-e1007439

2018

Volltextzugriff (PDF)

Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease

PloS one, 2007-12, Vol.2 (12), p.e1318

2007

Volltextzugriff (PDF)

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

Antimicrobial Agents and Chemotherapy, 2007-09, Vol.51 (9), p.3168-3176

2007

Volltextzugriff (PDF)

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

Nature communications, 2022-01, Vol.13 (1), p.558-14, Article 558

2022

Volltextzugriff (PDF)

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Antiviral research, 2016-02, Vol.126, p.62-68

2016

Volltextzugriff (PDF)

Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies

The Journal of Microbiology, 2017, 55(3), , pp.183-195

2017

Volltextzugriff (PDF)

Variation in lipid A structure in the pathogenic yersiniae

Molecular microbiology, 2004-06, Vol.52 (5), p.1363-1373

2004

Volltextzugriff (PDF)

Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir

Virology (New York, N.Y.), 2017-11, Vol.511, p.175-183

2017

Volltextzugriff (PDF)

Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever

Antiviral research, 2015-09, Vol.121, p.132-137

2015

Volltextzugriff (PDF)

Type I interferon underlies severe disease associated with Junín virus infection in mice

eLife, 2020-05, Vol.9

2020

Volltextzugriff (PDF)

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Antiviral research, 2013-11, Vol.100 (2), p.446-454

2013

Volltextzugriff (PDF)

T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.782-787

2011

Volltextzugriff (PDF)

Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy

Antiviral research, 2017-09, Vol.145, p.131-135

2017

Volltextzugriff (PDF)

Rift Valley fever virus infection in golden Syrian hamsters

PloS one, 2015-01, Vol.10 (1), p.e0116722-e0116722

2015

Volltextzugriff (PDF)

Kinetics of Disease Progression and Host Response in a Rat Model of Bubonic Plague

The American journal of pathology, 2005-05, Vol.166 (5), p.1427-1439

2005

Volltextzugriff (PDF)

TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection

Journal of Immunology, 2006-11, Vol.177 (9), p.6301-6307

2006

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(115)
Berichte
(1)

Sprache

Englisch
(116)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(81)
Animals
(79)
Humans
(41)
Pharmacology & Pharmacy
(41)
Female
(38)
Virology
(38)
Biological And Medical Sciences
(36)
Disease Models, Animal
(32)
Medical Sciences
(31)
Antiviral Agents
(30)
Mice
(29)
Pharmacology. Drug Treatments
(28)
Cricetinae
(24)
Antiviral Agents - Therapeutic Use
(23)
Arenavirus
(23)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(22)
Viruses
(22)
Infections
(20)
Phlebovirus
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever

Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses

A potent Lassa virus antiviral targets an arenavirus virulence determinant

Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies

Variation in lipid A structure in the pathogenic yersiniae

Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir

Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever

Type I interferon underlies severe disease associated with Junín virus infection in mice

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture

Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy

Rift Valley fever virus infection in golden Syrian hamsters

Kinetics of Disease Progression and Host Response in a Rat Model of Bubonic Plague

TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection

Suchergebnisse filtern